• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒(SARS-CoV-2)与宿主细胞和抗体的相互作用:实验与模拟。

Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation.

机构信息

Institute of Physics, Polish Academy of Sciences, al. Lotnikow 32/46, 02-668 Warsaw, Poland.

Institute of Fundamental and Applied Sciences, Duy Tan University, Ho Chi Minh City 700000, Vietnam.

出版信息

Chem Soc Rev. 2023 Sep 18;52(18):6497-6553. doi: 10.1039/d1cs01170g.

DOI:10.1039/d1cs01170g
PMID:37650302
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the devastating global COVID-19 pandemic announced by WHO in March 2020. Through unprecedented scientific effort, several vaccines, drugs and antibodies have been developed, saving millions of lives, but the fight against COVID-19 continues as immune escape variants of concern such as Delta and Omicron emerge. To develop more effective treatments and to elucidate the side effects caused by vaccines and therapeutic agents, a deeper understanding of the molecular interactions of SARS-CoV-2 with them and human cells is required. With special interest in computational approaches, we will focus on the structure of SARS-CoV-2 and the interaction of its spike protein with human angiotensin-converting enzyme-2 (ACE2) as a prime entry point of the virus into host cells. In addition, other possible viral receptors will be considered. The fusion of viral and human membranes and the interaction of the spike protein with antibodies and nanobodies will be discussed, as well as the effect of SARS-CoV-2 on protein synthesis in host cells.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是世界卫生组织(WHO)于 2020 年 3 月宣布的毁灭性全球 COVID-19 大流行的病原体。通过前所未有的科学努力,已经开发出几种疫苗、药物和抗体,挽救了数百万人的生命,但随着 Delta 和 Omicron 等令人关注的免疫逃逸变体的出现,抗击 COVID-19 的斗争仍在继续。为了开发更有效的治疗方法,并阐明疫苗和治疗剂引起的副作用,需要更深入地了解 SARS-CoV-2 与其和人类细胞的分子相互作用。我们对计算方法特别感兴趣,将重点研究 SARS-CoV-2 的结构及其刺突蛋白与人类血管紧张素转化酶 2(ACE2)的相互作用,因为这是病毒进入宿主细胞的主要切入点。此外,还将考虑其他可能的病毒受体。将讨论病毒和人类膜的融合以及刺突蛋白与抗体和纳米抗体的相互作用,以及 SARS-CoV-2 对宿主细胞蛋白质合成的影响。

相似文献

1
Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation.新冠病毒(SARS-CoV-2)与宿主细胞和抗体的相互作用:实验与模拟。
Chem Soc Rev. 2023 Sep 18;52(18):6497-6553. doi: 10.1039/d1cs01170g.
2
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.竞争性 SARS-CoV-2 血清学研究表明,大多数针对刺突受体结合域的抗体竞争与 ACE2 结合。
mSphere. 2020 Sep 16;5(5):e00802-20. doi: 10.1128/mSphere.00802-20.
3
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.SARS-CoV-2 变体 B.1.617.1 (Kappa)、B.1.617.2 (Delta) 和 B.1.618 的细胞进入和免疫逃逸特性。
mBio. 2022 Apr 26;13(2):e0009922. doi: 10.1128/mbio.00099-22. Epub 2022 Mar 10.
4
SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins.SARS-CoV-2 刺突蛋白变体与血管紧张素转化酶 2 融合糖蛋白的结合亲和力。
PLoS One. 2022 Dec 6;17(12):e0278294. doi: 10.1371/journal.pone.0278294. eCollection 2022.
5
Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.基于 SARS-CoV-2 刺突蛋白/血管紧张素转化酶 2 复合物的丙氨酸扫描计算和结构分析。
ACS Nano. 2020 Sep 22;14(9):11821-11830. doi: 10.1021/acsnano.0c04674. Epub 2020 Aug 26.
6
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
7
Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.通过密度泛函紧束缚片段分子轨道方法获得的 SARS-CoV-2 病毒和人血管紧张素转换酶 2 受体蛋白相互作用的热点图谱。
Sci Rep. 2020 Oct 8;10(1):16862. doi: 10.1038/s41598-020-73820-8.
8
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.SARS-CoV-2 刺突蛋白与人 ACE2 受体相互作用的蛋白质结构分析:从构象变化到新型中和抗体。
Cell Mol Life Sci. 2021 Feb;78(4):1501-1522. doi: 10.1007/s00018-020-03580-1. Epub 2020 Jul 4.
9
Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).通过中断严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白与血管紧张素转换酶2(ACE2)之间的相互作用来实现SARS-CoV-2早期进入的潜在治疗方法。
Biochem Pharmacol. 2021 Oct;192:114724. doi: 10.1016/j.bcp.2021.114724. Epub 2021 Aug 8.
10
SARS-CoV-2 Spike Protein Is Capable of Inducing Cell-Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies.SARS-CoV-2 刺突蛋白能够独立于其受体 ACE2 诱导细胞-细胞融合,而这种活性可以被弗林蛋白酶抑制剂或一组单克隆抗体所抑制。
Viruses. 2023 Jul 4;15(7):1500. doi: 10.3390/v15071500.

引用本文的文献

1
Biophysics of SARS-CoV-2 spike protein's receptor-binding domain interaction with ACE2 and neutralizing antibodies: from computation to functional insights.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白受体结合域与血管紧张素转换酶2(ACE2)及中和抗体相互作用的生物物理学:从计算到功能见解
Biophys Rev. 2025 Mar 8;17(2):309-333. doi: 10.1007/s12551-025-01276-z. eCollection 2025 Apr.
2
Neuropilin-1 Protein May Serve as a Receptor for SARS-CoV-2 Infection: Evidence from Molecular Dynamics Simulations.神经纤毛蛋白 1 可能作为 SARS-CoV-2 感染的受体:来自分子动力学模拟的证据。
J Phys Chem B. 2024 Jul 25;128(29):7141-7147. doi: 10.1021/acs.jpcb.4c03119. Epub 2024 Jul 15.
3
Nanobody engineering: computational modelling and design for biomedical and therapeutic applications.
纳米抗体工程:用于生物医学和治疗应用的计算建模与设计
FEBS Open Bio. 2025 Feb;15(2):236-253. doi: 10.1002/2211-5463.13850. Epub 2024 Jun 19.
4
SARS-CoV-2 Omicron Subvariants Do Not Differ Much in Binding Affinity to Human ACE2: A Molecular Dynamics Study.SARS-CoV-2 奥密克戎亚变种与人 ACE2 的结合亲和力差异不大:一项分子动力学研究。
J Phys Chem B. 2024 Apr 11;128(14):3340-3349. doi: 10.1021/acs.jpcb.3c06270. Epub 2024 Apr 2.
5
Deciphering the free energy landscapes of SARS-CoV-2 wild type and Omicron variant interacting with human ACE2.解析与人类 ACE2 互作的 SARS-CoV-2 野生型和奥密克戎变异株的自由能景观。
J Chem Phys. 2024 Feb 7;160(5). doi: 10.1063/5.0188053.